#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA693619	F	Tested in vitro for the cytotoxicity as number of viable cells against Hep-2 cell line after 72 hr treatment at conc. of 10E-6	Homo sapiens	1	ALA1124685	cell-based format	Scientific Literature
2.	ALA696943	F	Tested in vitro for the dose inhibiting cell proliferation by 50% against HeLa cell line after 24 hr treatment at conc. of 10E-6	Homo sapiens	8	ALA1124685	cell-based format	Scientific Literature
3.	ALA702572	F	In vitro inhibitory activity against Doxorubicin resistant L1210 leukemia cell lines ( ratio between IC50 values on resistant cells and sensitive cells)	Mus musculus	13	ALA1127778	cell-based format	Scientific Literature
4.	ALA702573	F	In vitro inhibitory activity against FCE 24517 resistant L1210 leukemia cell lines ( ratio between IC50 values on resistant cells and sensitive cells)	Mus musculus	13	ALA1127778	cell-based format	Scientific Literature
5.	ALA706136	F	Tested in vitro for the cytotoxicity as number of viable cells against L1210 cell line after 72 hr treatment at conc. of 10E-6	Mus musculus	8	ALA1124685	cell-based format	Scientific Literature
6.	ALA704399	F	Median survival time of treated to the control mice with L1210 tumor cells	Mus musculus	5	ALA1124685	cell-based format	Scientific Literature
7.	ALA707140	F	In vitro test for cytotoxicity after 48 hr of continuous exposure against L1210 murine leukemia cells	Mus musculus	24	ALA1129802	organism-based format	Scientific Literature
8.	ALA707105	F	In vitro inhibition of L1210 murine leukemia (Drug sensitivity was determined by counting surviving cells after 48 hr of continuous exposure to at least 4 conc. of drug)	Mus musculus	8	ALA1149967	cell-based format	Scientific Literature
9.	ALA707106	F	In vitro inhibition of L1210 murine leukemia (Drug sensitivity was determined by counting surviving cells after 48 hr of continuous exposure to at least 4 conc. of drug)	Mus musculus	8	ALA1151591	cell-based format	Scientific Literature
10.	ALA703643	F	Optimal dose was measured in vivo on L1210 murine leukemia cells in CD2F1 mice(ip)	Mus musculus	9	ALA1127778	organism-based format	Scientific Literature
11.	ALA702605	F	Optimal dose in mice (sub LD10 mg/kg).	Mus musculus	21	ALA1129802	organism-based format	Scientific Literature
12.	ALA702609	A	Tested in vivo for optimal non-toxic dose against L1210 cell line in CDF1 mice	Mus musculus	6	ALA1124685	organism-based format	Scientific Literature
13.	ALA708785	F	The activity in vitro on L1210 murine leukemia cells, activity expressed as IC50	Mus musculus	13	ALA1127778	cell-based format	Scientific Literature
14.	ALA703610	F	Tested in vitro for the cytotoxicity as number of viable cells against L1210/LPAM cell line after 72 hr treatment at conc. of 10E-6	Mus musculus	8	ALA1124685	cell-based format	Scientific Literature
15.	ALA703611	A	Tested in vivo for optimal non-toxic dose against L1210/LPAM cell line in CDF1 mice	Mus musculus	6	ALA1124685	organism-based format	Scientific Literature
16.	ALA703612	F	Median survival time of treated to the control was determined in L1210/LPAM cell line	Mus musculus	6	ALA1124685	cell-based format	Scientific Literature
17.	ALA707250	F	In vivo median survival time of treated vs untreated mice x 100 against murine L1210 leukemia cells after ip treatment on day 1 after tumor iv transplant	Mus musculus	11	ALA1133770	organism-based format	Scientific Literature
18.	ALA707251	F	In vivo median survival time of treated vs untreated mice x 100 against murine L1210 leukemia cells after iv treatment on day 1 after tumor iv transplant	Mus musculus	15	ALA1133770	organism-based format	Scientific Literature
19.	ALA707297	F	In vitro cytotoxicity against L1210 murine leukemia cells	Mus musculus	10	ALA1133246	cell-based format	Scientific Literature
20.	ALA710181	F	Inhibition of growth in L1210 leukemia cells resistant to Tallimustine.	Mus musculus	20	ALA1133770	cell-based format	Scientific Literature